XML 26 R6.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Reporting Entity | 12 Months Ended
--- | ---
Mar. 31, 2022
Reporting Entity |
Reporting Entity | 1. Reporting Entity OKYO Pharma Limited (the “Company” or “OKYO”) is a company domiciled in Guernsey and listed with a standard listing on the main market of the London Stock Exchange (LSE) and on the Nasdaq Capital Market (LSE: OKYO, NASDAQ: OKYO). The Company is developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. Our goal is to develop first in class drug candidates that prevent the disease instead of controlling it, and we achieve this through our collaboration with pioneer scientists in the field. The ultimate parent of the group is Panetta Partners Limited, incorporated in the British Virgin Islands.

X
- Definition Disclosure of Reporting Entity Explanatory. + References No definition available. + Details
Name: | OKYO_DisclosureOfReportingEntityExplanatory
Namespace Prefix: | OKYO_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | OKYO_DisclosureReportingEntityAbstract
Namespace Prefix: | OKYO_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration